Levers | Barriers |
Personal contacts/researcher policy contact/serendipity | Poor communication by researchers; ambivalence/hostility by researchers and research brokers |
Potential for good cost-benefit information | |
Independence of evaluators from policy/politicians | Problems if policy initiative to which politicians have committed themselves shown not to work |
Funding for new initiatives tied to good trial evidence/accountability | Cost/complexity of running a trial |
Advocacy by those whose trials have shown an effect in other countries | Ambivalence/hostility by some researchers and research brokers |
Good dissemination skills by trialists; willingness to avoid too many caveats when presenting results | Over-enthusiasm by some trial proponents |
A lot of good research on what the problems are; less on what to do about them | Pejorative use of term ‘experimentation’ |
Convincing trial welcome to politicians | Lack of high-quality trial applications |
Support from key government departments (eg, Treasury) | Moral and ethical concerns/equipoise |
Lack of researcher experience in social policy trials | |
Recruitment problems | |
Timing (in relation to policy development)/political desire to get things up and running quickly | |
RCTs more suited to clinical research | |
The line of least resistance not to carry them out | |
Culture of advocacy, case study, precedent and anecdote |
RCTs, randomised controlled trials.